Boyce Sarah
CIK 0001629383
President and CEODirector
Filings
33
Latest Mar 2, 2026
Issuers covered
5
Showing
33 of 33
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Boyce Sarah. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Boyce Sarah has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RNA | Avidity Biosciences, Inc. | 25 | Feb 27, 2026 |
| OABI | Omniab, Inc. | 4 | Jun 21, 2024 |
| CTNM | Contineum Therapeutics, Inc. | 2 | Jun 26, 2025 |
| RNA | Atrium Therapeutics, Inc. | 1 | Mar 2, 2026 |
| LGND | Ligand Pharmaceuticals Inc | 1 | Jun 13, 2022 |
All filings
33 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|